<DOC>
	<DOCNO>NCT00485017</DOCNO>
	<brief_summary>The purpose study evaluate safety effect THR-4109 weight loss obese subject 24-week treatment period .</brief_summary>
	<brief_title>Efficacy Safety THR-4109 Obese Subjects</brief_title>
	<detailed_description />
	<criteria>30 60 year age Body mass index 30 40 kg/m2 Women child bear potential negative pregnancy test prior entry agree use acceptable method contraception throughout study Able willing give write informed consent Weight loss 3 kg previous 3 month Current previous use ( within 3 month ) medication influence weight Known endocrine origin obesity , hypothyroidism Cushing 's syndrome Current history eat disorder bulimia , anorexia nervosa , binge eat laxative abuse Current serious/unstable medical condition Current pharmacologically treat diabetes fast plasma glucose â‰¥ 126 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Weight Loss</keyword>
</DOC>